World Scientific
  • Search
  •   
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Tue, Oct 25th, 2022 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.

Halogenated derivatives of cytidine: Structural analysis and binding affinity

    https://doi.org/10.1142/S0219633620500339Cited by:17 (Source: Crossref)

    Cytidine is a well-known inhibitor of DNA methyltransferase (MTN) enzyme for preventing cancer cells growth. Based on therapeutic benefits, it could be considered as a “lead compound” to be optimized through structural modification for arising better binding affinity in this case. Halogenated derivatives of cytidine were investigated in this work to examine structural and biological features employing in silico approach. To this aim, geometries of the original cytidine and four of its halogenated derivatives were minimized to prepare ligands for interacting with MTN enzyme target in molecular docking simulations. The results for singular ligand structures introduced I-cytidine as an optimized lead compound for contributing to proper interactions with MTN enzyme; the trend was confirmed by molecular docking simulations. As a final remark, I-cytidine could be considered as better ligand for complexation with the MTN enzyme in comparison with the original cytidine.

    References

    • 1. Siegel RL, Miller KD, Jemal A , Cancer Statistics, CA Cancer J Clin 69 :7–34, 2019. Web of ScienceGoogle Scholar
    • 2. Irvine I, Walshe T, Capra M, Hayes R , Scurvy: an unusual complication of paediatric cancer treatment, Skeletal Radiol 48 :995–998, 2019. Web of ScienceGoogle Scholar
    • 3. Ye L, Zhang Y, Chen YJ, Liu Q , Anti-tumor effects of lidocaine on human gastric cancer cells in vitro, Bratislava Med J 120 :212–217, 2019. Google Scholar
    • 4. Lyko F , The DNA methyltransferase family: A versatile toolkit for epigenetic regulation, Nature Rev Gen 19 :81–92, 2018. Web of ScienceGoogle Scholar
    • 5. Stoddard CI, Feng S, Campbell MG, Liu W, Wang H, Zhong X, Bernatavichute Y, Cheng Y, Jacobsen SE, Narlikar GJ , A nucleosome bridging mechanism for activation of a maintenance DNA methyltransferase, Mol Cell 73 :73–83, 2019. Web of ScienceGoogle Scholar
    • 6. Barau J, Teissandier A, Zamudio N, Roy S, Nalesso V, Hérault Y, Guillou F, Bourc’his D , The DNA methyltransferase DNMT3C protects male germ cells from transposon activity, Science 354 :909–912, 2016. Web of ScienceGoogle Scholar
    • 7. Herzig MC, Zavadil JA, Street K, Hildreth K, Drinkwater NR, Reddick T, Herbert DC, Hanes MA, McMahan CA, Reddick RL, Walter CA , DNA alkylating agent protects against spontaneous hepatocellular carcinoma regardless of O6-methylguanine-DNA methyltransferase status, Cancer Prevent Res 9 :245–252, 2016. Web of ScienceGoogle Scholar
    • 8. Ding N, Bonham EM, Hannon BE, Amick TR, Baylin SB, O’Hagan HM , Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage, J Mol Cell Biol 8 :244–254, 2016. Web of ScienceGoogle Scholar
    • 9. Zhao JY, Liang L, Gu X, Li Z, Wu S, Sun L, Atianjoh FE, Feng J, Mo K, Jia S, Lutz BM , DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons, Nature Commun 8 :14712, 2017. Web of ScienceGoogle Scholar
    • 10. Boosani CS, Gunasekar P, Block M, Jiang W, Zhang Z, Radwan MM, Agrawal DK , Inhibition of DNA methyltransferase-1 instigates the expression of DNA methyltransferase-3a in angioplasty-induced restenosis, Canadian J Physiol Pharmacol 96 :1030–1039, 2018. Web of ScienceGoogle Scholar
    • 11. Fukuhara TK, Visser DW , Cytidine derivatives, J Am Chem Soc 77 :2393–2395, 1955. Web of ScienceGoogle Scholar
    • 12. Showell GA, Mills JS , Chemistry challenges in lead optimization: silicon isosteres in drug discovery, Drug Discover Today 8 :551–556, 2003. Web of ScienceGoogle Scholar
    • 13. Mirzaei M, Hadipour NL , A computational NQR study on the hydrogen-bonded lattice of cytosine-5-acetic acid, J Comput Chem 29 :832–838, 2008. Web of ScienceGoogle Scholar
    • 14. Mirzaei M, Hadipour NL , Study of hydrogen bonds in crystalline 5-nitrouracil. Density functional theory calculations of the O-17, N-14, and H-2 nuclear quadrupole resonance parameters, J Iran Chem Soc 6 :195–199, 2009. Web of ScienceGoogle Scholar
    • 15. Mirzaei M, Gülseren O, Hadipour N , DFT explorations of quadrupole coupling constants for planar 5-fluorouracil pairs, Comput Theor Chem 1090 :67–73, 2016. Web of ScienceGoogle Scholar
    • 16. Mirzaei M , Effects of carbon nanotubes on properties of the fluorouracil anticancer drug: DFT studies of a CNT-fluorouracil compound, Int J Nano Dimens 3 :175–179, 2013. Google Scholar
    • 17. Veljkovic N , Recent in silico resources for drug design and discovery, Cur Med Chem 26 :3836–3837, 2019. Web of ScienceGoogle Scholar
    • 18. Sehgal SA, Hammad MA, Tahir RA, Akram HN, Ahmad F , Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design, Cur Neuropharmacol 16 :649–663, 2018. Web of ScienceGoogle Scholar
    • 19. Mirzaei M , Science and engineering in silico, Adv J Sci Eng 1 :1–2, 2020. Google Scholar
    • 20. Wadood A, Ahmed N, Shah L, Ahmad A, Hassan H, Shams S , In-silico drug design: An approach which revolutionarised the drug discovery process, OA Drug Des Deliver 1 :3–7, 2013. Google Scholar
    • 21. Pence HE, Williams A , ChemSpider: An online chemical information resource, J Chem Edu 87 :1123–1124, 2010. Web of ScienceGoogle Scholar
    • 22. Frisch MJ et al., Gaussian 09, Revision D.01, Gaussian. Inc., Wallingford CT, 2013. Google Scholar
    • 23. Becke AD , Becke’s three parameter hybrid method using the LYP correlation functional, J Chem Phys 98 :5648–5652, 1993. Web of ScienceGoogle Scholar
    • 24. Lee C, Yang W, Parr RG , Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Phys Rev B 37 :785–789, 1988. Web of ScienceGoogle Scholar
    • 25. Binkley JS, Pople JA, Hehre WJ , Self-consistent molecular orbital methods. 21. Small split-valence basis sets for first-row elements, J Am Chem Soc 102 :939–947, 1980. Web of ScienceGoogle Scholar
    • 26. Pietro WJ, Francl MM, Hehre WJ, Defrees DJ, Pople JA, Binkley JS , Self-consistent molecular orbital methods. 24. Supplemented small split-valence basis-sets for 2nd-row elements, J Am Chem Soc 104 :5039–5048, 1982. Web of ScienceGoogle Scholar
    • 27. Dobbs KD, Hehre WJ , Molecular-orbital theory of the properties of inorganic and organometallic compounds. 4. Extended basis-sets for 3rd row and 4th row, main-group elements, J Comp Chem 7 :359–378, 1986. Web of ScienceGoogle Scholar
    • 28. Ditchfield R, Hehre WJ, Pople JA , Self-consistent molecular orbital methods. 9. Extended Gaussian-type basis for molecular-orbital studies of organic molecules, J Chem Phys 54 :724–728, 1971. Web of ScienceGoogle Scholar
    • 29. Weigend F, Ahlrichs R , Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy, Phys Chem Chem Phys 7 :3297–3305, 2005. Web of ScienceGoogle Scholar
    • 30. Reed AE, Weinstock RB, Weinhold F , Natural-population analysis, J Chem Phys 83 :735–746, 1985. Web of ScienceGoogle Scholar
    • 31. HyperChem(TM) Professional 8.0, Hypercube, Inc., 1115 NW 4th Street, Gainesville, Florida 32601, USA, 2007. Google Scholar
    • 32. Khan AU , Descriptors and their selection methods in QSAR analysis: paradigm for drug design, Drug Discover Today 21 :1291–1302, 2016. Web of ScienceGoogle Scholar
    • 33. Bernstein FC, Koetzle TF, Williams GJ, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M , The protein data bank: A computer-based archival file for macromolecular structures, Eur J Biochem 80 :319–324, 1977. Google Scholar
    • 34. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X , Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation, Nature 449 :248–251, 2007. Web of ScienceGoogle Scholar
    • 35. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ , AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J Comput Chem 30 :2785–2791, 2009. Web of ScienceGoogle Scholar
    • 36. Tahmasebi E, Shakerzadeh E , Potential application of B40 fullerene as an innovative anode material for Ca-ion batteries: In silico investigation, Lab-in-Silico 1 :16–20, 2020. Google Scholar
    • 37. Harismah K, Mirzaei M , Steviol and iso-steviol vs. cyclooxygenase enzymes: In silico approach, Lab-in-Silico 1 :11–15, 2020. Google Scholar
    • 38. Gunaydin S, Alcan V, Mirzaei M, Ozkendir OM , Electronic structure study of Fe substituted RuO2 semiconductor, Lab-in-Silico 1 :7–10, 2020. Google Scholar
    • 39. Faramarzi R, Falahati M, Mirzaei M , Interactions of fluorouracil by CNT and BNNT: DFT analyses, Adv J Sci Eng 1 :62–66, 2020. Google Scholar
    • 40. Mirzaei M, Harismah K, Da’I M, Salarrezaei E, Roshandel Z , Screening efficacy of available HIV protease inhibitors on COVID-19 protease, J Mil Med 22 :100–107, 2020. Google Scholar
    • 41. Ghanadian M, Ali Z, Khan IA, Balachandran P, Nikahd M, Aghaei M, Mirzaei M, Sajjadi SE , A new sesquiterpenoid from the shoots of Iranian Daphne Mucronata Royle with selective inhibition of STAT3 and Smad3/4 cancer-related signaling pathways, DARU J Pharm Sci 28 :253–262, 2020. Web of ScienceGoogle Scholar
    • 42. Gowher H, Jeltsch A , Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy, Cancer Biol Therap 3 :1062–1068, 2004. Web of ScienceGoogle Scholar
    • 43. Lu LJ, Tseng WC, Randerath K , Effects of 5-fluorocytidine on mammalian transfer RNA and transfer RNA methyltransferases, Biochem Pharmacol 28 :489–495, 1979. Web of ScienceGoogle Scholar
    • 44. Kitchen DB, Decornez H, Furr JR, Bajorath J , Docking and scoring in virtual screening for drug discovery: methods and applications, Nature Rev Drug Discover 3 :935–949, 2004. Web of ScienceGoogle Scholar
    • 45. Partovi T, Mirzaei M, Hadipour NL , The C-HO hydrogen bonding effects on the 17O electric field gradient and chemical shielding tensors in crystalline 1-methyluracil: A DFT study, Z Naturforsch A 61 :383–388, 2006. Web of ScienceGoogle Scholar
    Remember to check out the Most Cited Articles!

    Check out our Chemistry New Titles